Aspirin/Pravastatin Stronger In Combination For CHD Secondary Prevention
This article was originally published in The Tan Sheet
Executive Summary
A combination of aspirin with the cholesterol-lowering drug pravastatin is 92% likely to provide a synergistic effect in secondary prevention of myocardial infarction, according to research published in the Jan. 12 Archives of Internal Medicine